Evidence map›Paper›PMID 24897504›Full record

Trial reportPloS one2014

Effects of prophylactic and therapeutic paracetamol treatment during vaccination on hepatitis B antibody levels in adults: two open-label, randomized controlled trials.

Anne M C M Doedée, Greet J Boland, Jeroen L A Pennings, Arja de Klerk, Guy A M Berbers, Fiona R M van der Klis, Hester E de Melker, Henk van Loveren, Riny Janssen

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02807623 ("Do NSAIDS or Executing Exercise Decrease Local Erythema, Site Swelling & Pain After INoculation), which is not on this map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02807623 nacompletednot on this mapstarted 2016, after this paper: background citation

"Do NSAIDS or Executing Exercise Decrease Local Erythema, Site Swelling & Pain After INoculation: the NEED LESS PAIN Study"

TypeinterventionalSponsorWomack Army Medical CenterRan2016 to 2018Enrolled300ConditionsImmune System and Related DisordersArmsIbuprofen, Compound Exercise of Push-ups, oral placebo
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Acetaminophen: A hazard to immunotherapy.Annals of medicine and surgery (2012) · 2022
    Article
  9. Review
  10. Article
  11. Revision of ICH S8 Needed?Frontiers in toxicology · 2022
    Article
  12. [Vaccinations].Der Internist · 2021
    Article
  13. Article
  14. Review
  15. Let fever do its job: The meaning of fever in the pandemic era.Evolution, medicine, and public health · 2021
    Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Anne M C M DoedéeCentre for Health Protection, National Institute for Public Health and the Environment, Bilthoven, The Netherlands; Department of Toxicogenomics, Maastricht University Medical Centre, Maastricht, The Netherlands.
Greet J BolandMedical Microbiology and Virology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Jeroen L A PenningsCentre for Health Protection, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Arja de KlerkCentre for Health Protection, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Guy A M BerbersCentre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Fiona R M van der KlisCentre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Hester E de MelkerCentre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Henk van LoverenCentre for Health Protection, National Institute for Public Health and the Environment, Bilthoven, The Netherlands; Department of Toxicogenomics, Maastricht University Medical Centre, Maastricht, The Netherlands.
Riny JanssenCentre for Health Protection, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
National Institute for Public Health and the Environment · NLMaastricht University Medical Centre · NLUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledWorldwide, paracetamol is administered as a remedy for complaints that occur after vaccination. Recently published results indicate that paracetamol inhibits the vaccination response in infants when given prior to vaccination. The goal of this study was to establish whether paracetamol exerts similar effects in young adults. In addition, the effect of timing of paracetamol intake was investigated. In two randomized, controlled, open-label studies 496 healthy young adults were randomly assigned to three groups. The study groups received paracetamol for 24 hours starting at the time of (prophylactic use) - or 6 hours after (therapeutic use) the primary (0 month) and first booster (1 month) hepatitis B vaccination. The control group received no paracetamol. None of the participants used paracetamol around the second booster (6 months) vaccination. Anti-HBs levels were measured prior to and one month after the second booster vaccination on ADVIA Centaur XP. One month after the second booster vaccination, the anti-HBs level in the prophylactic paracetamol group was significantly lower (p = 0.048) than the level in the control group (4257 mIU/mL vs. 5768 mIU/mL). The anti-HBs level in the therapeutic paracetamol group (4958 mIU/mL) was not different (p = 0.34) from the level in the control group. Only prophylactic paracetamol treatment, and not therapeutic treatment, during vaccination has a negative influence on the antibody concentration after hepatitis B vaccination in adults. These findings prompt to consider therapeutic instead of prophylactic treatment to ensure maximal vaccination efficacy and retain the possibility to treat pain and fever after vaccination.

trial registrationControlled-Trials.com ISRCTN03576945.

Indexed as

AcetaminophenAdolescentAdultFemaleFeverHepatitis BHepatitis B AntibodiesHepatitis B VaccinesHepatitis B virusHumansImmunity, ActiveMaleMiddle AgedVaccinationYoung AdultAcetaminophenHepatitis B AntibodiesHepatitis B Vaccines

Identifiers

PMID24897504
PMCPMC4045752
OpenAlexW2051414892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.